Relaunch of the Xenios Website – now harmonized with that of its parent, Fresenius Medical Care

The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com With this ...

View our latest brochure Heart and Lung Assist for Pediatric Patients

View our latest brochure Heart and Lung Assist for Pediatric Patients.

Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019

Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019.

Novalung at ESCIM Paris 2018 Session and Workshop Report

The results of the ECMO to rescue lung injury in severe ARDS (EOLIA) trial have long been awaited, since the first two trials in this field were already conducted decades ago and the results were controversial. The investigators around Prof. Alain Combes showed now in the largest international randomized multicentre setup so far, that ...

Originally launched as Novalung Academy, present-day Xenios Academy is celebrating its tenth anniversary. With training courses, studies and clinical support, Xenios AG assists its customers in everyday clinic work in the field of extracorporeal lung and heart support. Having undergone many years of continuing development, the concept for knowledge ...